Can Women with Systemic Lupus Erythematosus Safely Use Exogenous Estrogens?
Jill P. Buyon(New York University), Bevra H. Hahn(University of California, Los Angeles), Joan T. Merrill(Oklahoma Medical Research Foundation), Christianne Yung(University of California, Los Angeles), H. Michael Belmont(New York University Langone Orthopedic Hospital), Lisa R. Sammaritano(Hospital for Special Surgery), Michelle Petri(Johns Hopkins University), Mary Louise Skovron(Albert Einstein College of Medicine), Kenneth Kalunian(University of California, San Diego), Robert G. Lahita(St. Luke's-Roosevelt Hospital Center), Frederick Licciardi(Bellevue Hospital Center)
Cited by 57
Related Papers
Scientific monograph of the Quebec Task Force on Whiplash-Associated Disorders: redefining "whiplash" and its management.
|PubMed|1995|1.9k
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
|New England Journal of Medicine|2005|1.1k
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Autoimmune-Associated Congenital Heart Block: Demographics, Mortality, Morbidity and Recurrence Rates Obtained From a National Neonatal Lupus Registry
|Journal of the American College of Cardiology|1998|748
Postoperative complications and mortality associated with operative delay in older patients who have a fracture of the hip.
|Journal of Bone and Joint Surgery|1995|621